The reporting requirements for research will be therefore burdensome.

February 13th, 2018

CMS urged to limit description of study for reporting under Doctor Payment Sunshine Act Expressing concerns that lots of physicians will become discouraged from conducting medical analysis due to cumbersome reporting requirements and potential mischaracterizations of their income, the Association of Clinical Research Companies is urging the Centers for Medicare & Medicaid Services to adopt a restricted definition of analysis for purposes of reporting under the Physician Payment Sunshine Act.D. As proposed, the reporting requirements for ‘research’ will be therefore burdensome, and yield such complicated information, that the costs incurred would considerably exceed any public advantage that we can see. Related StoriesGenomic Wellness announces Medicare protection for Oncotype DX prostate malignancy testASTRO worried about proposed Medicare physician payment cuts to radiation therapyMedicare patients in rural settings have lower prices of post-discharge follow-up careThe reporting requirements were included as Section 6002 of the individual Protection and Affordable Treatment ACT .It does switch the equation quite drastically. But the drug is described in the latest Nice help with colorectal malignancy. Two American professionals commenting in The Lancet pointed out some limitations to the study. Dr Andrew Chan and Dr Nancy Make, from Harvard Medical School in Boston, said the analysis didn’t include findings from two huge US trials that didn’t show an anti-cancer benefit from taking aspirin every other day.

Other entries from category "diagnostics":

Random entries